Literature DB >> 16914551

The amino terminus of the human multidrug resistance transporter ABCC1 has a U-shaped folding with a gating function.

Qun Chen1, Youyun Yang, Lang Li, Jian-Ting Zhang.   

Abstract

Multidrug resistance is a serious problem in successful cancer chemotherapy. Studies using model cell lines have demonstrated that overexpression of some members of the ATP-binding cassette (ABC) transporter superfamily, such as ABCC1, causes enhanced efflux and, thus, decreased accumulation of multiple anticancer drugs, which leads to increased cell survival. Unlike most other ABC transporters, ABCC1 has an additional membrane-spanning domain (MSD0) with a putative extracellular amino terminus of 32 amino acids. However, the function of MSD0 and the role of the extracellular amino terminus are largely unknown. In this study, we examined the structural folding and the function of the amino terminus. We found that it has a U-shaped folding with the bottom of the U-structure facing cytoplasm and both ends in extracellular space. We also found that this U-shaped amino terminus probably functions as a gate to regulate the drug transport activity of human ABCC1.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16914551     DOI: 10.1074/jbc.M603529200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  13 in total

1.  Human ABCC1 interacts and colocalizes with ATP synthase α, revealed by interactive proteomics analysis.

Authors:  Youyun Yang; Zhaomin Li; Wei Mo; Raghuram Ambadipudi; Randy J Arnold; Petra Hrncirova; Milos V Novotny; Elias Georges; Jian-Ting Zhang
Journal:  J Proteome Res       Date:  2012-01-18       Impact factor: 4.466

2.  14-3-3σ Contributes to Radioresistance By Regulating DNA Repair and Cell Cycle via PARP1 and CHK2.

Authors:  Yifan Chen; Zhaomin Li; Zizheng Dong; Jenny Beebe; Ke Yang; Liwu Fu; Jian-Ting Zhang
Journal:  Mol Cancer Res       Date:  2017-01-13       Impact factor: 5.852

3.  Role of transmembrane segment 5 and extracellular loop 3 in the homodimerization of human ABCC1.

Authors:  Youyun Yang; Wei Mo; Jian-Ting Zhang
Journal:  Biochemistry       Date:  2010-12-02       Impact factor: 3.162

4.  Transverse and tangential orientation of predicted transmembrane fragments 4 and 10 from the human multidrug resistance protein (hMRP1/ABCC1) in membrane mimics.

Authors:  Béatrice de Foresta; Michel Vincent; Manuel Garrigos; Jacques Gallay
Journal:  Eur Biophys J       Date:  2011-06-24       Impact factor: 1.733

5.  FASN regulates cellular response to genotoxic treatments by increasing PARP-1 expression and DNA repair activity via NF-κB and SP1.

Authors:  Xi Wu; Zizheng Dong; Chao J Wang; Lincoln James Barlow; Valerie Fako; Moises A Serrano; Yue Zou; Jing-Yuan Liu; Jian-Ting Zhang
Journal:  Proc Natl Acad Sci U S A       Date:  2016-10-24       Impact factor: 11.205

6.  Colchicine Binding Site Agent DJ95 Overcomes Drug Resistance and Exhibits Antitumor Efficacy.

Authors:  Kinsie E Arnst; Yuxi Wang; Zi-Ning Lei; Dong-Jin Hwang; Gyanendra Kumar; Dejian Ma; Deanna N Parke; Qiang Chen; Jinliang Yang; Stephen W White; Tiffany N Seagroves; Zhe-Sheng Chen; Duane D Miller; Wei Li
Journal:  Mol Pharmacol       Date:  2019-05-01       Impact factor: 4.436

Review 7.  Multidrug resistance-associated protein 1 (MRP1/ABCC1) polymorphism: from discovery to clinical application.

Authors:  Jiye Yin; Jianting Zhang
Journal:  Zhong Nan Da Xue Xue Bao Yi Xue Ban       Date:  2011-10

8.  Different roles of TM5, TM6, and ECL3 in the oligomerization and function of human ABCG2.

Authors:  Wei Mo; Jing Qi; Jian-Ting Zhang
Journal:  Biochemistry       Date:  2012-04-19       Impact factor: 3.162

9.  Dynamic vs static ABCG2 inhibitors to sensitize drug resistant cancer cells.

Authors:  Hui Peng; Jing Qi; Zizheng Dong; Jian-Ting Zhang
Journal:  PLoS One       Date:  2010-12-07       Impact factor: 3.240

Review 10.  Redox regulation of multidrug resistance in cancer chemotherapy: molecular mechanisms and therapeutic opportunities.

Authors:  Macus Tien Kuo
Journal:  Antioxid Redox Signal       Date:  2009-01       Impact factor: 8.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.